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Abstract 
 
Title: The association between Attention Bias Modification and basal cortisol in individuals 
with vulnerability for reoccurring depression  
Author: Inger Marie Andreassen 
Supervisor and co-supervisors: Nils Inge Landrø, Catherine Harmer and Rune Jonassen 
 
Background and research aim: Depression constitutes a great burden in the world 
population, with its high reoccurrence rates. One of the factors in both the maintenance and 
reoccurrence in depression is a negative attention bias, which leads to an increase in stress 
appraisal. The current study aimed to investigate the association between modifying a 
negative attention bias and basal circadian cortisol variations in previously depressed 
individuals.  
Methods: The data in the current study was collected from the project “Secondary 
prevention of depression applying an experimental Attention Bias Modification procedure”, 
where the author has worked and been part of the data collecting process. 52 participants who 
had a history of depression but who were currently in remission were recruited, and received 
either an active or placebo version of a computerized Attention Bias Modification (ABM) 
task, over 14-days consisting of 28 sessions in total. The participants’ basal circadian cortisol 
variations were measured using three saliva samples for each time of measurement, pre-
intervention, after 14 days and at one-month follow up. A mixed between-within analysis of 
variance was used in the analyses of the data.  
Results: Even though there were no statistically significant differences between the 
basal circadian cortisol variations at either time of measurement between the two groups, 
there were tendencies in the predicted direction with a reduction in basal cortisol in the active 
ABM group. A general learning effect of the ABM task, entailing a decrease in reaction times 
were found in both groups although the ABM task did not appear to have a specific effect on 
positive vigilance. There was however fluctuations in the attention biases in both groups, and 
these fluctuations appeared to be smaller in the active ABM group.  
Conclusion: Attention biases in remission phases of depression might reflect more 
dynamic processes instead of stable traits, influenced by mood. Reducing fluctuations in 
these biases through the ABM task might reduce residual symptoms like a heightened level 
of basal cortisol. The current null-findings could have been affected by different factors: 
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number of previous depressive episodes, remission criteria, comorbid anxiety disorders, 
establishing reliable basal circadian cortisol measures, and sample size. The findings of the 
current study is considered to be a small but important contribution to the field of attention 
bias modification and depression, in terms of re-evaluating different aspects of the 
intervention. 
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1 Introduction 
  
1.1 Background – depression, a “leading cause of world disability” 
Depression stems from the Latin word deprimere, which means; “to press down, depress” 
(Oxford Dictionaries Online, n.d.). As a construct today, depression is used to describe what 
is considered to be the clinical form of a lowered mood, or being pressed down, with its key 
characteristics. The World Health Organization (WHO) defines depression as “a common 
mental disorder, characterized by sadness, loss of interest or pleasure, feelings of guilt or low 
self-worth, disturbed sleep or appetite, feelings of tiredness, and poor concentration” 
(Marcus, Yasamy, Van Ommeren, Chisholm, & Saxena, 2012). This definition entails both 
the psychological, physiological and the executive features of depression. The different 
components affect and reinforce each other at various levels. The psychological themes 
evolve around a negative evaluation of one self, rejection from others, loneliness, 
helplessness and a loss of meaning (Beck, 2008). These themes affect and are affected by 
important components in depression which are cognitive biases in attention, perception and 
memory. Both the psychological and executive components appear to influence the stress 
response system. Dysregulation in the stress response system with a heightened level of basal 
cortisol is one of the physiological features in depression, that is also frequently seen also in 
remission periods (Huber, Issa, Schik, & Wolf, 2006).  
Depression is a huge burden for both the people suffering from it, and for the society 
as a whole, when accounting for years lost due to disability. According to WHO (Marcus et 
al., 2012) depression is the most highly occurring psychiatric disorder in the world, with a 
lifetime prevalence of 17%. Further WHO estimates that “by 2020, depression will be the 
second leading cause of world disability” (Marcus et al., 2012), “and by 2030 the largest 
contributor to disease burden” (Marcus et al., 2012).  
Depression has an estimated reoccurrence rate of about 80% (Browning, Holmes, 
Charles, Cowen, & Harmer, 2012). It is difficult to find the most effective targeted 
psychotherapy and psychopharmacology treatments to prevent reoccurrence in depression. 
Antidepressants appear not to have the desired effects on many people suffering from 
depression, and different forms of psychotherapy have variable degrees of success rates 
(Cuijpers, Smit, Bohlmeijer, Hollon, & Andersson, 2010; Kirsch et al., 2008). An increased 
knowledge of the phenomenon depression, its underlying and maintaining factors, and how to 
target these, are therefore necessary and important. New forms of treatments that target 
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maintaining factors in order to prevent reoccurring episodes can make important 
contributions in the attempt to reduce the burden of the disorder.  
 
1.2 Negative attention bias  
Cognitive biases with regards to both detecting negative information through 
attention, and memory biases for negative events have been proposed as maintaining factors 
in depression (Mathews & MacLeod, 2005). Both people suffering from depression and those 
in remission appears to have a heightened memory for recalling negative events (Mathews & 
MacLeod, 2005). In order to perceive a situation as negative one has to detect and attend to 
negative stimuli. A negative attention bias has been established as an underlying mechanism 
for reoccurrence in depression, and has been proposed to increase the degree of reactivity to 
stress (Browning et al., 2012; De Raedt & Koster, 2010; Gotlib, Krasnoperova, Yue, & 
Joormann, 2004; Koster, Fox, & MacLeod, 2009; Mathews & MacLeod, 2005). A bias can 
be defined as “a tendency to process information so as to favor types of emotional valence or 
meaning” (Mathews & MacLeod, 2005). According to Beck (2008) a bias towards negative 
stimuli stems from cognitive schemas. Cognitive schemas are defined by Beck as “a 
cognitive structure for screening, coding, and evaluating the stimuli that impinge on the 
organism” (Beck, 1967). In other words, a schema is a way of organizing information into 
categories (e.g different experiences). Taken into account the extreme number of stimuli a 
person is exposed to every day, we are dependent on efficient information processing in order 
to adapt to and cope with our surroundings. Categorizing allows information processes to be 
automated, making us capable to process several stimuli at a time and adapt quickly.  
However, schemas can also be dysfunctional and maladaptive, which is often seen in 
depression. Certain experiences can have a greater impact on the organization of for example 
self-schemas, which are “accessible information about the self” (Hammen, Marks, DeMayo, 
& Mayol, 1985). Early adverse events like the loss of a parent in childhood, can lead to 
dysfunctional attitudes about one self, like “If I loose a loved one I am helpless”(Beck, 2008) 
or “I am alone in the world”. These attitudes can become unified into self-schemas that 
contains central themes in depression like hopelessness and loneliness that can lead to loss of 
motivation and suicidal wishes. Such schemas can be viewed as a cognitive vulnerability for 
depression (Beck, 2008). Similar experiences at a later point in time that evoke associations 
to the early negative event(s), can activate the depressive self-schemas. The cognitive 
schemas can be viewed as the center of a complex network, encompassing behavioral, 
affective, motivational and physiological components. When this network is fully activated, it 
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represents the numerous symptoms of depression, and becomes resistant to external influence 
like positive stimuli. The resources from adaptive schemas are disproportionally distributed 
to the dysfunctional schema(s), reducing a person’s ability for coping and problem solving 
(Beck, 2008). Thus resulting in a negative bias in information processing, which can be 
argued to be the core mechanism in the maintenance and recurrence in depression (Beck, 
2008). See Figure 1. Repeated activation of the dysfunctional cognitive schemas leads to a 
“kindling effect” (Beck, 2008) which means that with time they become more readily 
activated, and more resistant to change. As with neurons, when the network is activated, the 
connections between the different components are strengthened “cells that fire together, wire 
together”(Schatz, 1992). Consistent with the fact that for each depressive episode the 
probability for recurring episodes increases (Browning et al., 2012; Liu & Alloy, 2010).  
According to Beck (1967), individuals suffering or recovering from depression, will 
only show a negative attention bias towards stimuli that are compatible with their depressive 
schemas. This bias appears to be most prominent with regards to stimuli of interpersonal 
significance, like facial expressions (Gotlib et al., 2004; Liu & Alloy, 2010). Such stimuli can 
activate depressive schemas, which lead to a suppression of more positive, adaptive schemas. 
A negative attention bias entails that already at the encoding level, the attention is drawn to 
possible, negative stimuli. The decoding part of a detected negative stimulus will be done 
during activation of a depressive schema, leading to a negative evaluation of the situation. 
Such situations will be perceived as stressful, activating the stress response system. A 
negative attention bias therefore leads to a more frequent generation of stress at an 
information processing level through the detection of negative stimuli.  
In individuals who are in remission from depression, these schemas or networks are 
latent but not activated. However, depressive self-schemas appear to change with mood 
(Beck, 2008; Hammen et al., 1985). A negative attention bias can be viewed as a more stable 
trait when the depressive schemas are fully activated during a depressive episode. In 
remission, these biases might be more fluctuating in accordance with mood induced 
activation of these schemas. In a study by Zvielli, Amir, Goldstein, and Bernstein (2015) it is 
suggested that attention biases might be better understood and regarded as dynamic processes 
instead of static traits. Zvielli et al. (2015) proposes that it is the underlying biased emotional 
attention towards content specific stimuli (i.e. threatening stimuli in anxiety disorders, and 
negative facial expression in depression), which fluctuate and has to be addressed in order to 
modify the attention biases.   
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The current study will not focus on genetic vulnerabilities in depression, but it is still 
worth mentioning that not all individuals that experiences early adverse life events develop 
depression. There appears to be individual predisposing vulnerabilities with regards to 
genetic variations affecting both attention and the stress response system, which interacts 
with stressful experiences leading to the development of depression, and making these 
individuals more prone to the development of depressive self-schemas, as described (Beck, 
2008).  
 
Figure 1. Becks model of information processing in the cognitive model of depression  
 
 
Note. The illustration of the model is retrieved from the article by Disner, Beevers, Haigh, and Beck 
(2011) in Nature Reviews. 
 
1.3 The stress response system and cortisol 
Stress and coping are two closely related concepts. The definition of stress can be 
understood in terms of an organism’s capacity or incapacity to cope with a stressful stimulus. 
When the demands of a situation or certain circumstances exceeds an organism’s perceived 
resources, or ability to cope, it can be defined as stressful (McEwen, 1998). Stress can be 
further defined as either acute or chronic. Acute stress is a short-term stress response to a 
stressful stimulus that can elicit adaptive responses in terms of the fight or flight response, 
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which consists of rapid changes in neurotransmitters and hormones enabling us to quickly 
respond in a threatening situation. The stress response system is an adaptive or allostatic 
system, that adapts to stimuli in order to maintain and regain homeostasis or equality in the 
body’s internal environment.” Allostasis is the ability to achieve stability through change” 
(McEwen, 1998). When the stress response system for some reason is unable to adapt to 
changes, it leads to a physiological stress reaction that can be referred to as chronic stress or 
allostatic load (McEwen, 1998). Acute and chronic stress has different effects on the central 
nervous system.  
 
1.3.1 The short- and long-term effects of stress on the central nervous system 
There are two main systems involved in stress responses. Even though these are 
connected, they play different roles in the immediate and the more prolonged responses to 
stress. The sympathetic-adrenomedullary (SAM) system is involved in the fight or flight 
response through the instant release of mainly epinephrine (adrenalin) from the central 
adrenal glands, preparing the muscles to fight or flee (Gunnar & Quevedo, 2007). The 
hypothalamic-pituitary-adrenocortical (HPA) system initiates the slower and more prolonged 
responses to stressors, through the release of glucorticoids (GCs), which in humans are 
mainly cortisol. The effects of cortisol are more gradual as opposed to the instant effects of 
adrenalin. The pathway of cortisol release starts in the paraventricular nuclei (PVN) of the 
hypothalamus, were both corticotrophin-releasing hormone (CRH) and arginine vasopressin 
(AVP) are released. CRH and AVP affect the anterior pituitary’s release of 
adrenocorticotropic hormone (ACTH), which travels to the adrenal glands attaching to 
receptors, which elicits the release of cortisol (Gunnar & Quevedo, 2007). Cortisol, unlike 
adrenaline, crosses the blood-brain barrier to a much higher degree, affecting the central 
nervous system to a greater extent. Levels of cortisol can be affected by a number of different 
factors like age, gender, seasonal changes, circadian rhythm, medications and psychological 
disorders (Kirschbaum & Hellhammer, 1994; Pariante, Thomas, Lovestone, Makoff, & 
Kerwin, 2004; Van Cauter, Leproult, & Kupfer, 1996; Wehr, 1998).   
 
1.3.2 The stress response system in depressed and previously depressed individuals - 
the damaging effects of long duration exposure to high cortisol levels 
People suffering from depression seem to have a dysregulated stress response system. 
There is an increased reactivity of the amygdala, which may escalate the frequency of stress 
appraisal (Beck, 2008). This leads to an increase in cortisol release throughout circadian 
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rhythms, 24-hours variations, which can result in hypercortisolism, an excessive release of 
cortisol at both resting states and in response to stressful situations (Holsboer, 2001). These 
prolonged elevated cortisol levels, makes it hard for the stress response system to react and 
activate the needed amount of extra resources when faced with stressors (Harkness, Stewart, 
& Wynne-Edwards, 2011). 
Cortisol interacts with two different receptors; glucorticoid receptors (GR) and 
mineralocorticoid receptors (MR). MR keeps the everyday functions of the systems operative, 
while GR make us adapt in more stressful situations, where we need to access more resources 
than what is required in initial functioning. Cortisol has a higher binding affinity to MR, and 
only when cortisol exceeds initial levels during stressful situations, does cortisol bind to GR. 
Cortisol has important and beneficial functions in the central nervous system. With initial to 
moderate levels of cortisol acting through MR and GR, neural plasticity is enhanced by 
reducing the refractory period of neurons in the hippocampus. This means that the neurons 
reach their action potential more quickly, so that they are ready to fire and communicate with 
other neurons (de Kloet, Oitzl, & Joëls, 1999). However, when cortisol exceeds moderate 
levels, and a much higher percentage of GR receptors are occupied, this can lead to a 
reduction in glucose availability which over time can led to cell death. One of the brain areas 
which has a high density of cortisol receptors is the hippocampus and associated areas 
(McEwen, 1998). The hippocampus functions as a negative feedback site for the HPA system 
to regain homeostasis. High cortisol exposure over time, can lead to the loss of important 
receptors in this region for a functional regulation of the HPA axis. This can be caused by a 
down regulation of the number of receptors in order to regain homeostasis, and to possible 
destruction of these receptors as a result of high cortisol levels that become toxic. The results 
can be hypercortisolism, frequently seen in depression (Holsboer, 2001). Some studies have 
shown a higher risk for relapse associated with reduced negative feedback ability, in 
previously depressed individuals currently in remission (Zobel et al., 2001). This indicates 
that some individuals have a continued dysregulation of the HPA axis even in remission, 
which appears to be a risk factor for recurring depressive episodes. Somatic consequences of 
hypercortisolism over time can lead to secondary illnesses like osteoporosis, atherosclerosis, 
metabolic syndromes and reduced immune system capacity. Left untreated, these diseases 
contribute to a reduction in life expectancy by 15-20 years (Tsigos & Chrousos, 2002) 
Other structures in the limbic system such as the amygdala in addition to prefrontal 
structures, also modulates and controls the HPA system (Gunnar & Quevedo, 2007). The 
amygdala is crucial for emotional interpretation and consolidation of emotional events. It also 
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plays an important role in activating the HPA system to psychosocial stressors. Frequent and 
high levels of stress can lead to a sensitization of the amygdala, which entails easily evoked 
responses to stressors, due to a lowered threshold for action potentials in neurons, making 
activation easy (Gunnar & Quevedo, 2007). In resemblance to cognitive schemas, this 
represents a kindling effect. In depressed and previously depressed individuals, the capacity 
of top-down control of limbic structures from prefrontal areas seems to be reduced, while 
limbic activation, especially in the amygdala, appears to be increased, or hyper responsive 
(Beck, 2008).  
The stress response system and its ability to efficiently up and down regulate itself when 
faced with stressors (McEwen, 1998), is dependent on the initial value of basal cortisol levels 
(Lacey, 1956). Basal cortisol, or baseline levels, refers to an individuals normal level of 
cortisol concentrations when the system is not faced with stressors. If the overall basal 
cortisol levels are high, this can result in a reduced reactivity, meaning that the stress 
response system has a decreased ability to react adaptively to stress, with regards to both up 
and down regulation, due to initial high basal cortisol. Basal cortisol variations follows a 
curve according to circadian rhythms, variations over 24 hours, where cortisol levels are 
highest in the early morning hours, and then gradually decline in the evening, reaching a low 
point around midnight (Wehr, 1998). In both depressed and previously depressed individuals, 
this curve of cortisol between evening to morning seems to be flatten (Sjögren, Leanderson, 
& Kristenson, 2006), due to high basal cortisol concentrations.  
The current study looks at basal circadian cortisol variations from evening to morning, 
which can be used as an assessment of HPA axis functioning. By assessing the variations 
from evening to morning, at three different times over a one-month period, where possible 
changes in cortisol levels will be compared. This gives a more comprehensive view of the 
tonic instead of just the phasic variations in cortisol. Phasic changes entail more rapid 
changes during a short time-interval, like the cortisol awakening response (CAR), where 
cortisol samples are taken during one consecutive hour after awakening. Especially a blunted 
CAR in depressed and previously depressed patients has been a consistent finding (Huber et 
al., 2006). The tonic changes that emerge over time, ranging from daily variations to weeks 
and months, are less investigated.  
The effect of cortisol on executive functioning, including attention, has been widely 
studied (Andreotti, Garrard, Venkatraman, & Compas, 2014). Cognitive functioning during a 
depressive episode have been shown to be negatively affected (Preiss et al., 2009). It appears 
that even when in remission, previously depressed individuals score significantly lower than 
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never depressed controls on both the Trail Making test, part B and on the STROOP color-
word task. These tests both measures executive functioning, and respectively degree of 
cognitive flexibility with regards to alternate-switch abilities, and degree of inhibition control 
(Meiran, Diamond, Toder, & Nemets, 2011; Preiss et al., 2009). In addition, number of 
previous depressive episodes have been indicated to affect the degree of cognitive 
impairment in remission (Biringer et al., 2005).  
There appears to be a relationship between cognitive components and cortisol. Whether 
this relationship is one-directional or bi-directional is however less investigated. There is 
limited research on whether modifying cognitive components can affect cortisol.  
 
1.4 The relationship between a negative attention bias and cortisol 
Modifying a negative attention bias can be argued to lead to a reduction in stress 
appraisal, which would affect one of the residual symptoms of depression; high basal cortisol 
levels with subsequent reduced cortisol reactivity. 
 Assessing a stimuli as stressful happens when the individual perceives the stimuli or 
situation as over exceeding his or hers resources, or ability to cope. With a bias towards 
negative, content specific stimuli (e.g. sad faces and a sense of rejection) previously 
depressed individuals are vulnerable to negative mood changes. This has been hypothesized 
to activate depressive schemas, resulting in an appraisal of a reduced ability to cope. In turn, 
in an attempt to deal with the stressors, this leads to activation of the HPA axis in order to 
regain homeostasis. However, with a hyper responsive HPA axis, and possible reduced 
negative feedback ability, the body keeps releasing cortisol, resulting in high basal cortisol 
concentrations. In addition, the activation of depressive schemas will maintain a negative 
attention bias, which will continue the stressful assessment of the individual’s surroundings. 
In sum the negative attention bias and cortisol release becomes a feedback loop that reinforce 
each other, making people who have experienced one or more depressive episode, vulnerable 
for reoccurring episodes.  
The amygdala plays a crucial role in both stress responses and in evaluation of emotional 
stimuli. In previously depressed individuals there appears to be a hyper-responsive amygdala 
activation (Browning, Holmes, & Harmer, 2010). Modifying a negative attention bias that 
entails an over-representation of negative detected stimuli, could lead to a reduction in 
amygdala specific activation. A reduced hyper responsive amygdala, could affect the HPA 
axis in the direction of a possibly more adaptive stress response system with reduced basal 
cortisol concentrations, leading to a more efficient ability to up and down regulate itself when 
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faced with stressors. Changing a negative attention bias can therefore be argued to lead to a 
reduction in stress appraisal, which would affect one of the residual symptoms of depression; 
high basal circadian cortisol with subsequent reduced cortisol reactivity. 
One of the advantages with intervening at an attention level when people have recovered 
from a depressive episode is their increased ability to respond to external stimuli. As 
mentioned, a depressive episode can be viewed as a full-blown activation of the depressive 
network with its cognitive, physiological, behavioral and emotional components. When fully 
activated the network allows for little external influence to correct the dysfunctional attitudes 
that are present.  
 
1.5 The Attention Bias Modification (ABM) procedure 
Cognitive Bias Modification (CBM) have been a field of research aiming to target and 
modifying biases with regards to attention, interpretation and memory (MacLeod, Koster, & 
Fox, 2009). Through computerized procedures with different content and duration, although 
still in its early stages, this research has shown some promising results with regards to 
transference to clinical applications (Browning et al., 2010; Koster & Bernstein, 2015). One 
of the most commonly used CBM techniques developed to target attention biases in 
depression is the Attention Bias Modification (ABM) procedure (Koster & Bernstein, 2015). 
Findings of a negative attention bias in depressed and previously depressed individuals, has 
been especially consistent when the stimuli presented has been mood congruent faces, instead 
of words. Processing of pictures and faces depends on a different system than processing of 
words. Faces and pictures seems to have an easier access to the system where emotional 
information is stored (Gotlib et al., 2004). Building on the principle that previously depressed 
individuals have a content specific attention bias especially with regards to stimuli of 
interpersonal significance (e.g. faces) that can activate depressive schemas, the ABM uses 
faces that are of different emotional valence.  
Studies using CBM procedures has shown promising results especially in patients 
suffering from anxiety disorders (MacLeod et al., 2009). In a study using an ABM procedure 
with people diagnosed with generalized social anxiety disorder (GAD), 72% of the 
participants in the active condition did not meet the criteria for GAD one month after the 
intervention compared to 11% in the control group (Schmidt, Richey, Buckner, & Timpano, 
2009). This effect gives an indication about ABM procedures being translational to clinical 
settings, and might also be possible to produce in samples of clinical depressed and 
previously depressed individuals. There is a high comorbidity between anxiety disorders and 
	   10	  
depression, and these affective disorders have some similar but yet distinctive features 
(Kaufman & Charney, 2000). For example, biases in anxiety disorders and depression might 
occur at different stages of the attention process. The attention bias in anxiety disorders 
appears to be an extremely quick, subconscious process, occurring from 10-500 milliseconds 
(ms). Whereas in depression, the attention bias seems to entail the later stages of attention 
occurring from 500-1000ms, with an additional problem of disengaging attention away from 
negative stimuli (Browning et al., 2010; Gotlib et al., 2004).  
Having a more positive attention bias appears to “protect against the negative effects of 
stressful environmental interactions” (Browning et al., 2012), which increases previously 
depressed individuals coping skills when faced with stressors. In the study by Browning et al. 
(2012) previously depressed individuals showed a decrease in morning cortisol 
concentrations following an active version of the ABM task. The sample size was however 
smaller than in the current study, and cortisol was only measured in the morning as opposed 
to investigating circadian cortisol variations as in the current study.  
The computerized active ABM task trains participants to attend to more positive faces, 
through a dot-probe paradigm. Participants are presented with pairs of facial expressions for a 
certain amount of ms, which are followed by one or two dot(s) behind the most positive 
weighted of the two faces. Valid trials are when the dot(s) appears after the most positive 
valence faces, while invalid trials are when the dot(s) appears behind the most negative 
valence face. In the active condition of the task, there are mostly valid trials. Participants then 
have to indicate with one of two keys on the keyboard, whether one or two dot(s) appeared. 
The underlying assumption is that through associative learning, which is a well-established 
phenomenon (Fanselow & Poulos, 2005), between positive facial expressions and the dot-
probe, participants gradually develop an attention towards more positively facial expressions 
over the training period that will be consolidated and generalized to their everyday life. This 
attention towards more positive weighted stimuli is thought to be a protection against stress, 
through both the reduced detection of negative stimuli and actions based on these negative 
evaluations.  The effects of different CBM tasks, have been shown to last for up until 4 
months when an increased amount of sessions are administrated over several weeks 
(MacLeod et al., 2009). As opposed to CBM tasks done at one single point in time, which has 
yielded effects lasting for only 20 minutes to 24 hours (Fox, Mackintosh, & Holmes, 2014). 
Consolidating an improved bias towards more positive valance facial expressions over time 
could be argued to increase the possibility of a more robust change in bias that would protect 
against stress vulnerability.  
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1.6 Summarized   
A negative attention bias is one of the maintaining factors in depression, which can be 
viewed as the center of depressive schemas. These schemas encompass emotional, cognitive 
and physiological components, one of which is a dysregulated stress response with an 
excessive cortisol release. In remission phases these schemas can be activated by negative 
mood changes. The negative attention bias and the excessive cortisol release becomes a 
feedback loop that reinforce each other, making people who have experienced one or more 
depressive episode, vulnerable for reoccurring episodes.  
The active version of the ABM task have been shown to have a positive effect on cortisol 
levels through its influence on attentions bias that have been proposed to work as a cognitive 
vaccine against residual symptoms including cortisol (Browning et al., 2012). Correction of a 
negative attention bias can therefore be said to reduce risk factors for recurring depressive 
episodes. 
 
1.7 Research hypotheses in the current study 
The current study has one primary outcome measures, basal circadian cortisol, which 
aims to explore the association between ABM and stress. The primary outcome measure is 
validated and used in three main research hypotheses:  
 
1. Measures of basal cortisol in previously depressed individuals will reveal a circadian 
pattern characterized by a drop in the evening and an increase in the morning from the first to 
the second morning sample.  
2. The active ABM condition will modify basal circadian cortisol levels. It is predicted that 
14-days of ABM training would be associated with lower basal circadian cortisol levels.  
3. The effect of ABM will be more noticeable after one-month follow-up than directly after 
the training procedure.  
 
The first hypothesis is that cortisol concentrations will increase from the first to the 
second morning sample, and decrease in the evening, in both of the groups at all three times 
of measurement. This is the expected circadian curve of normal basal cortisol. In previously 
depressed patients this curve can be somewhat blunted, but is still expected to have the same 
decrease in the evening, and increase in the morning. It is important to establish whether or 
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not these expected cortisol levels can be observed in both of the groups, before comparing 
possible differences due to the intervention.  
The second hypothesis is that there will be a difference in basal circadian cortisol 
variations between the two groups after the 14-days intervention. The third hypothesis is that 
this effect will be more apparent at one-month follow up than after 14-days. If affecting a 
negative attention bias can have an impact on morning cortisol levels as shown in the study 
by Browning et al. (2012) with a smaller sample, this effect should also be apparent in basal 
circadian cortisol variations, encompassing the changes from evening to morning. Some 
studies have found a maintained but also increased effect of cognitive bias modification task 
several months after the intervention (Schmidt et al., 2009). These increased effects might 
reflect an ongoing process and gradually consolidation of cognitive changes (MacLeod et al., 
2009). This might partly reflect changes in amygdala hyper responsiveness through a 
modification of a negative attention bias that would be gradual, with a reduced kindling effect 
of amygdala activation. Such possible effects would therefore be more apparent after a 
certain amount of time. The predicted differences in the cortisol curves are decreased basal 
cortisol concentrations in the evening and morning in the active ABM condition group, 
compared to the placebo ABM condition group. This reflects both phasic cortisol, defined as 
changes within cortisol curves over one consecutive day from evening to morning, and tonic 
changes that emerges over time, which is defined as the comparison of the three different 
cortisol curves over a one month period.  
 The secondary aims involve the ABM task itself. Establishing a general learning 
effect of the ABM task, meaning that both groups regardless of condition will show a general 
learning effect of the task, entailing a decrease in reaction time towards both valid and invalid 
trials over the 14 days intervention. This is an important assumption to establish at a group 
level, in order to ensure that the participants have completed their ABM sessions, which is a 
necessary prerequisite in order to compare possible differences between the placebo and 
active conditions. In addition, the ABM procedure is further explored by calculating the mean 
intra-individual learning effects and differences between valid and invalid trials, to 
investigate possible fluctuation in biases. These secondary aims may shed light over some of 
the controversies in CBM research. Studies have yielded results ranging from null-effects to 
statistically significant effects on clinically relevant outcome measures. These findings have 
however mostly been from small to moderate (Koster & Bernstein, 2015). Many studies 
investigating the effects of the ABM procedure, has not properly established the task in terms 
of establishing a general learning effect showing that participants regardless of conditions 
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have completed the task in a satisfactory way (i.e. completed session and paying attention 
during them). In addition, biases have mostly been studied as a stable trait, not as possibly 
more dynamic processes. This is important to review more closely, in order to validate the 
phenomenon one is trying to influence. Herein, the current study explores the ABM 
procedure by calculating the general inter-individual learning effect and differences between 
valid and invalid trials over the training procedure to look at possible fluctuation in biases.  
Secondary aims regarding the ABM task are:  
- Establishing a general learning effect of the ABM task.  
- Investigating possible fluctuations in biases. 
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2 Methods and materials  
 
2.1 Context 
The current study used data collected in the project ”Secondary prevention of depression 
applying an experimental Attention Bias Modification procedure”. The main project was 
started in 2014, and is based at the Department of Psychology at the University of Oslo 
(UiO). It is currently being conducted at both the University in Oslo and in two clinical 
centers in Norway. The project is lead by professor Nils Inge Landrø, in collaboration with 
the University of Oxford. The core aim of the main project is secondary prevention of 
depression in previously depressed adult patients, by modification of a negative attention bias 
through the computerized Attention bias modification (ABM) procedure, seen in relation to 
candidate genes for serotonin transportation/reuptake. The main project is ongoing, and will 
consist of results from approximately 400-500 participants when completed. The main 
project received funding from the research council of Norway, through the research 
programme on mental health in 2013. The main project is approved by the regional ethical 
committee (REC) 2014/217-1.  
The current study uses a sub-sample of the participants from the main project. The 
participants were recruited from, “Kveldspoliklinikken raskere tilbake” at Vinderen 
Distriktpsykiatriske senter (DPS), and had completed their one-month follow up between 
May 2014 and May 2015.  
 
2.2 Participants and recruitment  
In cooperation with the outpatient clinic at Vinderen DPS, Diakonhjemmet Hospital in 
Oslo, 76 participants with a history of one or more previous depressive episodes were 
recruited. Former patients previously treated for depression, consenting to be contacted from 
relevant research projects, received an invitation with detailed information about the study. 
The main aim of the study on the invitation was stated to be “investigating attention focus, 
how it changes over time and how it is related to mood and depressive symptoms”. The 
invitation also contained detailed information about what participation would entail and that 
participation was voluntary. There was also information stating that participation in the study 
would have no direct benefits or disadvantages to the participants. After the invitation had 
been received, employees from the study called the previous patients to inquire whether or 
not they were interested in participating, answering possible questions and giving additional 
	  15	  
information when required. Written consents were collected from the participants preceding 
the diagnostic assessment and evaluation for participation in the project.  
Inclusion criteria were a history of one or more previous depressive episodes, in addition 
to currently being in remission. This entailed meeting the criteria for one or more previous 
depressive episodes (ICD-10 F.32.0 Mild depressive episode, F32.1 Moderate depressive 
episode, F32.2 Severe depressive episode without psychotic symptoms or F.33.4 Recurrent 
depressive disorder, currently in remission(World Health, 1993)). Exclusion criteria`s were 
no current or past neurological illness, bipolar disorder, psychosis or drug addiction. 
Diagnostic assessment and evaluation of remission was made in accordance with the 
structured clinical interviews for DSM-IV criteria, The Mini International Neuropsychiatric 
Interview (M.I.N.I.), and the Beck Depression Inventory (BDI-II). Employees at the study 
trained in administrating M.I.N.I., conducted the assessment at the Department of Psychology 
at UiO.  
 
2.3 The Beck depression inventory II (BDI-II) 
The Beck depression inventory (BDI) was developed in 1961 based on clinical 
observations of depressed patients as a self-report screening tool encompassing the different 
aspects of clinical depression (Beck, Steer, & Carbin, 1988). There are 21 items with scores 
ranging from 0-3 on each item, reflecting symptom intensity during the last two weeks (Beck 
et al., 1988). The inventory takes approximately 5-10 minutes to fill out. The total score is 
achieved through adding the sum of scores on all the 21 items, giving a range of scores 
between 0-63. A score of 0-9 indicates a minimal of depressive symptoms, a score of 10-18 
indicates mild depression, a score from 19-29 indicates moderate depression and a score from 
30-63 indicate severe depression. The second edition, BDI-II is today widely used and 
accepted as a self-report measure that has a high inter-rater reliability and validity. In addition 
to discriminating depression from other mood disorders sharing many of the same features 
such as anxiety disorders (Beck et al., 1988; Dozois, Dobson, & Ahnberg, 1998; Riedel et al., 
2010). A BDI-II score of < 12 has been found by some to produce the highest degrees of 
sensitivity and specificity with regards to remission criteria (Riedel et al., 2010). The current 
study uses a BDI-II score of  < 12 as one of the remission criteria’s.  
Within the scope of the current study and its focus, BDI-II scores were only obtained 
preceding the intervention in order to compare self-reported symptom levels.  
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2.4 The Mini International Neuropsychiatric Interview (M.I.N.I) version 6.0.0 
The M.I.N.I. interview is a structured clinical interview, designed for brief 
assessments of 23 symptom disorders on axis 1 from the DSM, with yes or no answers 
(Mordal, Gundersen, & Bramness, 2010). When using the MINI interview for diagnostic 
assessments according to the ICD-10, the diagnostic guidelines in accordance with the ICD-
10 must also be met. Mordal et al. (2010) found a high inter-rater reliability (cohens kappa of 
.82) between interviewers for the Norwegian translated version, when assessing current and 
recurrent depressive disorder.  
 
2.5 The ABM Task 
The current study intervenes at the level of an implicit, systematic negative attention 
bias in emotional information processing. Attempting to modify this bias in order to attain a 
more functional attention focus, through a computerized ABM task. The participants are 
instructed to focus on a cross in the middle of the screen of a laptop, and indicate whether one 
or two dot(s) appear after a pair of faces is presented on the screen, using two different keys 
on the keyboard of the laptop. Pairs of facial expressions with different emotional valence, 
neutral, sad, or happy, appear next to each other and are presented for either 500ms or 
1000ms. Following are either one or two closely linked probes in one of the locations of the 
two faces, and the participant then have to indicate if one or two probes were presented. The 
reaction time is then measured assessing the amount of ms from when the dot(s) appeared to 
a key is pressed. Depressed and previously depressed individuals shows a faster reaction time 
when the probe(s) follows negative valence faces, as opposed to never depressed individuals 
who on the contrary shows a slower reaction time when the probe(s) follows negative facial 
expressions (Browning et al., 2012).  
There are two conditions in the current study, a placebo condition were there are no 
weighting towards either negative or positive valence faces, and an active condition. In order 
to correct the implicit negative attention bias, participants are given an active condition of the 
ABM procedure, where the probe(s) appears 87% of the time in the location of the most 
positive valence facial expression in the pairs (neutral-negative, negative-happy, happy-
neutral). In order to detect the probes, participants learn at an implicit level that there is an 
association between the probe(s) and the positive valence facial expressions, directing their 
attention towards the positive valence faces. This is thought to results in an associative 
learned attention bias towards positive stimuli.  
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Figure 2. The ABM task 
                         
Note. Depicting a valid trial from an ABM task, where the dot appears behind the most positive 
valence emotional expression to the right, and the presentation time of the faces are 1000ms.  
 
2.6 Measures of cortisol  
Cortisol concentrations in the current study were measured over a one-month period, at 
three different times: before the ABM intervention, after the 14-days intervention and at one-
month follow up. At each different time, three saliva samples were collected, giving a total of 
nine samples. Before the intervention: (1) in the evening before the starting the 14-days 
intervention, (2) upon awakening the same morning the participants started the ABM task, (3) 
15 minutes after awakening. After the 14-days ABM intervention: (4) the last evening of the 
intervention, (5) upon awakening the morning after completing the ABM task, (6) 15 minutes 
after the first morning sample. At one-month follow up: (7) in the evening, (8) upon 
awakening, (9) 15 minutes after the first morning sample.  
The cortisol saliva samples were collected using the Sarstedt Cortisol Salivette® Device, 
which consists of a tube with a cotton swab, that participants are instructed to chew on in 
order to attain a viable sample, and then place back into the tube. Participants were given 
instructions on how to collect these saliva samples at home, including time of sampling, 
which was in the evening between 20-22, and in the morning between 07-09. The participants 
were also told to avoid activities entailing exercise, use of tobacco, teeth brushing, eating and 
drinking 60 minutes before collecting the saliva sample, as they can affect cortisol 
concentrations and (Kirschbaum & Hellhammer, 1994). The samples were delivered by the 
participants to the Department of psychology at UiO and stored in a freezer at -18℃, and 
within 4 months all samples were transferred to -80℃ freezers. The samples are thawed on 
ice and cold centrifuged at 4℃, 2000 rpm for 15 minutes. The saliva is then transferred into 
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eppendorf tubes, which are stored in a -80℃ freezer. Samples are brought to Radbound 
University in Nijmegen on dry ice for radioimmunoassay (RIA) analysis.  
The protocol used for cortisol RIA in micro plates is refined by Gorissen et al. (2012). In 
short 3-5 plates were prepared each day, using 96-wells Micro-Assay-Plates (Greiner-Bio-
one: 655094; White/µClear - high-binding). Wells are prepared by adding cortisol antibody 
(Abcam: ab1949; Cortisol Antibody[xm210] monoclonal and IgG purified) diluted in coating 
buffer into all wells, except A-specifics that received coating buffer only. Plates were 
incubated overnight at 4℃. Following incubation wells were washed with wash buffer and 
then block buffer, consecutively plates were placed in heat cabinet at 37℃ for incubation. 
Saliva samples were thawed on ice for ∼1-2 hours. Blocking buffer was removed from the 
wells by decanting and immediately thereafter standards (Sigma: H4001-5G; Hydrocortisone 
≥98% HPLC), samples and controls (assay buffer) were added in duplicate. Finally 90µl 3H-
Cortisol tracer (PerkinElmer: #NET396250UC - Hydrocortisone (Cortisol,[1,2,6,7-3H(N)]-
),[1,2,6,7-3H(N)]- 250µCi(9.25MBq) was added into each well and left to cold incubate over 
night at 4℃. After incubation plates were repeatedly washed with wash buffer. Prior to β-
measurement scintillation solution was added to all the plates. Values that were obtained 
were directly translated into saliva cortisol concentrations. 
 
2.7 Procedure 
Participants were randomized to either the placebo or active ABM condition. It was a 
double blind study, were both the employees interviewing participants and the participants 
were blind to which condition they received. 
 
2.8 Statistical analysis and data reduction 
All analyses were conducted using IBM SPSS Statistics version 22.0.0.0. To explore 
possible group differences with regards to age, educational level, BDI-II scores, number of 
previous depressive episodes, independent t-tests were used. When comparing gender, and 
comorbid anxiety disorders, chi-squared tests were applied.  
Of the 76 participants some were excludes due to the following reasons: 14 of the 
participants were diagnosed as being in a current depressive episode. These participants were 
excluded, since the focus of the current study was attention bias modification in relation to 
basal circadian cortisol in previously depressed individuals. 8 participants were excluded du 
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to extreme levels of cortisol excretion more than 3 standard deviations from the group mean. 
2 participants were excluded due to more than 4 lost ABM sessions.  
In total 52 participants were include. 20 of these participants did also fulfilled the 
criteria’s for different anxiety disorders, including panic disorder, limited panic attacks, and 
social phobia. Given the high comorbidity between anxiety disorders and depression, it was 
expected that a relatively high number of the participants would also have a comorbid anxiety 
disorder (Kaufman & Charney, 2000), and these participants were included.  
10 participants lacked all of the three cortisol samples for the one-month follow up. This 
high number was mostly due to constraints in the cortisol analyses. Data analyses were 
carried out on all available data for the cortisol samples, which were 52 participants 
preceding the intervention, 52 after the 14-days intervention, and 42 at the one-month follow 
up, giving different sample sizes at the different times of measurement. See Figure 3.  
 
 
Note. Depicting number of participants in the two different conditions with respective sample sizes from 
randomization, at the 14-days follow up, and at the one-month follow up.  
 
The following model was used to investigate the hypotheses regarding basal circadian 
cortisol variations in both groups: a mixed between-within analysis of variance was 
conducted with the two ABM groups (placebo versus active) as the between-subjects factor, 
and the three samples pre intervention, at 14-days follow up and at one-month follow up, as 
within-subjects factors. The dependent variable was basal circadian cortisol, defined as the 
circadian variations from evening to morning.  
 
 
Figure 3. Overview of participants in the ABM conditions over the one-month period 
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Table 1.The cortisol samples at the different times of measurement 	  
   
Pre-intervention (T1) 
E (1) M1 (2) M2 (3) 
14-days follow up (T2) 
E (4) M1 (5) M2 (6) 
One month-follow up (T3) 
E (7) M1 (8) M2 (9)  
   
Note. Overview of the Evening (E), Morning 1(M1) and Morning 2 (M2) samples at the different times 
of measurement. 
 
To look at possible changes between the separate cortisol samples, the difference between 
corresponding samples were calculated (e.g. for comparison of T1 and T2, the difference 
score between E(4) and E(1), M1(5) and M1(2), and M2 (6) and M2 (3) was calculated). The 
same was done between all the three different times of measurement, T1, T2 and T3. See 
Table 1.  
The following model was used to investigate the secondary aims, which was that both of 
the groups would show a general learning effect of the ABM task and that there would be 
possible fluctuation in biases: a mixed between-within subjects analysis of variance was 
conducted with the two ABM groups (placebo versus active), as the between-subjects factor, 
and time over the 14-days intervention period as a within subjects factor. The dependent 
variable was reaction time.  
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3 Results 
3.1 Group demographics and baseline measures 
The two groups were well matched in all the samples both pre intervention, at 14-days 
follow up and at one-month follow up with regards to the demographic variables age and 
educational level. The age range was between 27-67 years. The groups were also well 
matched with regards to clinical variables entailing symptom levels measured by the BDI-II 
preceding the intervention and comorbid anxiety disorders. There was however a clear trend 
in differences between the groups when it came to number of previous depressive episodes.  
Since there was a variation in the number of participants in the two different 
conditions pre, at 14-days follow up and after one-month, separate t-tests and chi-squared 
tests were conducted for the groups pre intervention and at 14-days follow up, and after one 
month in order to compare possible differences between the two ABM condition groups also 
with regards to the different sample sizes.  
All effects are reported as significant at p < .05. 	  
 Placebo ABM 
 (n = 25) 
Active ABM 
(n=27) 
Placebo ABM 
(n= 18) 
Active ABM 
(n=24) 
Age Mean (SD), Years 43.9 (9.4) 41 (9.1) 45.33 (9.6) 41.25 (9.4) 
Sex, n, F:M 16:9 17:10 15:4 15:9 
Educational level, ISCED (SD),  2.5 (.6) 2.51 (.6) 2.57 (.5) 2.46 (.6) 
No. of previous episodes Mean (SD) 3.1 (1.3) 4.0 (2.2) 2.9 (1.2) 3.9 (.5) 
BDI-II scores pre, Mean (SD) 9.1 (7.1) 11.9 (6.3)    
Comorbid anxiety disorders , n         17 
 
14 
 
13 12 
     
     
 
Table 2. Participant demograpics and clinical information 
 	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  The sample pre and at                          The sample at  
                                                                                   14-days follow up                            one-mont follow up 
                                                                   (n = 52)                                              (n = 42) 
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ISCED level, referring to International Standard Classification of Education (Unesco, 
1997), was divided into three categories, 1 = upper secondary education, 2 = tertiary 
education 1-4 years, and 3 = tertiary education for more than 4 years. On average the 
participants in both groups had an educational level corresponding to tertiary education 
ranging from 1-4 years.  
The placebo groups mean symptom level on the BDI-II equaled a minimal of 
depressive symptoms, while the group mean symptom level in the active ABM group equaled 
mild depression. Both of the groups fulfilled the criteria for self-reported measure for 
remission, which was defined as a score of < 12. The mean level in the active group was 
11.9, meaning that this result was just within the criteria score for remission.  
In both the samples consisting of 52 and 42 participants, the placebo ABM group had 
a mean of around 3 previous depressive episodes, while the active ABM group had a mean of 
around 4 previous depressive episodes. In the sample consisting of 52 participants, there was 
a clear trend between the placebo ABM group and the active ABM group t(50) = -1.86, p = 
.07. In the sample consisting of 42 participants at one-month follow up, there was a clear 
trend between the placebo ABM group and the active ABM group t(41) = -1.89, p = .07. 
Since this difference was at a trend level it was included as a covariate.  
 	  
3.2 The curves of basal circadian cortisol from the different times of measurement 
The first hypothesis was that basal circadian cortisol variations would decrease in the 
evening and then increase from the first to the second morning sample, in both of the groups 
at all three times of measurement. This was a consistent finding at all the three times of 
measurement, pre intervention, at 14-days follow up and at one-month follow up. Before the 
intervention, there was a statistical significant main effect of time, Wilks` Lambda = .79, F 
(2, 48) = 6.60, p = .00. These results gave the predicted cortisol curve with a decrease in 
basal cortisol levels in the evening and an increase from the first to the second sample in the 
morning. See Figure 4. The same pattern was seen after the 14-days intervention, were there 
was also a statistically significant main effect of time, Wilks` Lambda = .61, F (2, 48) = 
15.44, p = .00. See Figure 5. At one-month follow up, this predicted cortisol curve persisted 
with a statistically significant main effect of time, Wilks` Lambda = .64, F (2, 38) = 10.51, p 
= .00. See Figure 6.  
In the basal circadian cortisol curve before the ABM intervention, the evening sample in 
the placebo ABM group had a mean of 1.32 with a standard error (SE) of 0.30, and in the 
active ABM group a mean of 0.69 and a SE of 0.14. The Morning 1 sample in the placebo 
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ABM group had a mean of 3.91 with a SE of 0.50, and the active ABM group had a mean of 
4.24 and a SE of 0.56. The Morning 2 sample in the placebo ABM group had a mean of 5.22 
and a SE of 0.54, and in the active ABM group with a mean of 5.85 and a SE of 0.76. See 
Figure 4. 
  
Figure 4. Basal circadian cortisol variations before the ABM intervention 
 
Note. Depicting basal circadian cortisol variations from evening to morning before the ABM 
intervention. Cortisol concentrations measured in nanogram(ng)per/milliliter(ml) in the evening 
(Evening), upon wakening (Morning 1) and 15 minutes after the first morning sample (Morning 2). 
The filled line shows the placebo ABM group, and the dotted line shows the active ABM group.  
 
3.3 Analyses of variance for the relationship between the ABM intervention and basal 
circadian cortisol levels 
The second hypothesis was that there would be a difference in basal circadian cortisol 
variations between the two groups after the 14-days intervention period. There was no 
statistically significant interaction effect between the ABM conditions and basal circadian 
cortisol after the 14-days intervention, Wilks` Lambda = .99, F (2, 48) = .30, p = .74. See 
Figure 5. There was no statistically significant interaction effect between number of previous 
depressive episodes and basal circadian cortisol variations after the 14-days intervention, 
Wilk`s Lambda = .95, F (2, 48) = 1.20, p = .32.  
In the basal circadian cortisol curve after the 14-days intervention period, the evening 
sample in the placebo ABM group had a mean of 1.34 with a SE of 0.22, and in the active 
ABM group a mean of 0.99 and a SE of 0.18. The Morning 1 sample in the placebo ABM 
group had a mean of 4.64 with a SE of 0.49, and the active ABM group had a mean of 4.57 
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and a SE of 0.51. The Morning 2 sample in the placebo ABM group had a mean of 5.72 and a 
SE of 0.56, and in the active ABM group with a mean of 5.47 and a SE of 0.65. See Figure 5. 
 
Figure 5. Basal circadian cortisol variations after the 14-days ABM intervention  
 
Note. Depicting basal circadian cortisol variations from evening to morning after the 14-days ABM 
intervention. Cortisol concentrations measured in ng/ml in the evening (Evening), upon wakening 
(Morning 1) and 15 minutes after the first morning sample (Morning 2). The filled line shows the 
placebo ABM group, and the dotted line shows the active ABM group.  
 
The third hypothesis was that the difference in basal circadian cortisol variations 
between the two groups would be more apparent at the one-month follow up. There was no 
statistically significant interaction effect between the ABM conditions and basal circadian 
cortisol at the one-month follow up, Wilks` Lambda = .97, F (2, 38) = .70, p = .51. See 
Figure 6. There was also no statistically significant interaction effect between number of 
previous depressive episodes and basal circadian cortisol variations at one-month follow up, 
Wilks` Lambda = .97, F (2, 38) = .47, p = .63.  
In the basal circadian cortisol curve at one-month follow up, the evening sample in 
the placebo ABM group had a mean of 0.96 with a SE of 0.26, and in the active ABM group 
a mean of 1.07 and a SE of 0.32. The Morning 1 sample in the placebo ABM group had a 
mean of 5.13 with a SE of 0.77, and the active ABM group had a mean of 3.81 and a SE of 
0.56. The Morning 2 sample in the placebo ABM group had a mean of 5.27 and a SE of 0.69, 
and in the active ABM group with a mean of 4.28 and a SE of 0.44. See Figure 6.  
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Figure 6. Basal circadian cortisol variations at one-month follow up  
 
Note. Depicting basal circadian cortisol variations from evening to morning at one month-follow up 
after the ABM training. Cortisol concentrations measured in ng/ml in the evening (Evening), upon 
wakening (Morning 1) and 15 minutes after the first morning sample (Morning 2). The filled line 
shows the placebo ABM group, and the dotted line shows the active ABM group.  
 
To look at possible changes between the different cortisol samples before the 
intervention, at 14-days follow up and at one-month follow up, difference scores were as 
previously mentioned calculated. There was no statistically significant interaction effect 
between the ABM conditions and difference scores in basal circadian cortisol from pre 
intervention to the 14-days follow up, Wilks` Lambda = .98, F (2, 48) = .54, p = .59. See 
Figure 7. There was no statistically significant interaction effect between number of previous 
depressive episodes and differences in basal cortisol variations between pre to the 14-days 
follow up, Wilks` Lambda = .95, F (2, 48) = 1.34, p = .27.  
The difference score for the Evening sample in the placebo ABM group had a mean of -
.02, and in the active ABM group a mean of .30. The difference score for the Morning 1 
sample in the placebo group had a mean of .73, and in the active ABM group a mean of .33. 
The difference score for the Morning 2 sample had a mean of .49 in the placebo ABM group, 
and a mean of -.39 in the active ABM group. See Figure 7.  
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Figure 7. Mean difference between cortisol samples pre intervention and at 14-days follow up 
in the two groups 
 
Note. Depicting the mean difference scores between the Evening, Morning 1 and Morning 2 samples 
from before and after the 14-days intervention. The filled line shows the placebo ABM group, and the 
dotted line shows the active ABM group.  
 
There was no statistically significant interaction effect between the ABM conditions 
and difference scores in basal circadian cortisol from the 14-days follow up to the one-month 
follow up, Wilks` Lambda = .95, F (2, 38) = 1.00, p = .38. . See Figure 8. There was no 
statistically significant interaction effect between number of previous depressive episodes 
and differences in basal cortisol variations between the 14-days follow up to the one-month 
follow up, Wilks` Lambda = .98, F (2, 38) = .45, p = .64. 
The difference score for the Evening sample in the placebo ABM group had a mean 
of -.14, and in the active ABM group a mean of .02. The difference score for the Morning 1 
sample in the placebo group had a mean of .52, and in the active ABM group a mean of -.80. 
The difference score for the Morning 2 sample had a mean of -.71 in the placebo ABM 
group, and a mean of -1.10 in the active ABM group. See Figure 8. 
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Figure 8. Mean differences between cortisol samples at the 14-days follow up and one-month 
follow up in the two groups 
 
Note. Depicting the difference scores between the Evening, Morning 1 and Morning 2 samples from 
the 14-dats follow up and the one-month follow up. The filled line shows the placebo ABM group, and 
the dotted line shows the active ABM group. 
 
There was no statistically significant interaction effect between the ABM conditions and 
difference scores in basal circadian cortisol from pre to the one-month follow up, Wilks` 
Lambda = .93, F (2, 38) = 1.46, p = .25. See Figure 9. There was no statistically significant 
interaction effect between number of previous depressive episodes and differences in basal 
circadian cortisol variations between from pre to the one-month follow up, Wilks` Lambda = 
.94, F (2, 38) = 1.12, p = .34.  
The difference score for the Evening sample in the placebo ABM group had a mean of     
-.15, and in the active ABM group a mean of .44. The difference score for the Morning 1 
sample in the placebo group had a mean of 1.21, and in the active ABM group a mean of       
-.45. The difference score for the Morning 2 sample had a mean of -.14 in the placebo ABM 
group, and a mean of -1.85 in the active ABM group. See Figure 9.  
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Figure 9. Mean difference between cortisol samples pre intervention and at one-month follow 
up in the two groups 
 
Note. Depicting the difference scores between the Evening, Morning 1 and Morning 2 samples from 
the before the intervention and one-month follow up. The filled line shows the placebo ABM group, 
and the dotted line shows the active ABM group.  
  
 
 
 
 
 
 
 
Table 3.  Difference scores for basal circadian cortisol variations between the two groups at the different 
times of measurement 
 
 Pre (T1) to 14-days 
follow up (T2) 
14-days follow up (T2) to 
one-month follow up (T3) 
Pre (T1) to one-month 
follow up (T2) 
  Placebo 
(n = 25) 
Active 
(n = 27) 
Placebo 
(n = 18) 
Active 
(n = 24) 
Placebo 
(n = 18) 
Active 
(n = 24) 
Evening Mean (SE)  .02 (.19) .30 (.17) -.14 (.30) .02 (.38) -.15 (.39) .44 (.36) 
Morning 1, Mean (SE)  .73 (.53) .33 (.44) .52 (.88) -.80 (.62) 1.21 (.79) -.45 (.74) 
Morning 2, Mean (SE)  .49 (.55)  -.39 (.68) -.71 (.75) -1.10 (.74) -.14 (.76) -1.85 (.88) 
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3.4 Secondary aims 
3.4.1 The general learning effect of the ABM task 
One of the secondary aims was that both groups would show a general learning effect 
over the 14-days intervention, towards both valid and invalid trials over the 14-days 
intervention with the ABM task.  
There was a statistically significant main effect of time for valid trials, Wilks` Lambda = 
.33, F (13, 36) = 5.58, p = .00. See Figure 10. 
 
Figure 10. Reaction times towards valid trials 
 
Note. The mean average of reaction times towards valid trials (i.e. positive valence faces) from each 
of the 14-days intervention for both of the groups.   
 
There was also a statistically significant main effect of time for invalid trials, Wilks` 
Lambda = .30, F (13, 36) = 6.35, p = .00. See Figure 11.   
In sum, there was a statistical significant difference between reaction times towards 
both valid and invalid trials from the beginning of the 14-days training period until the end of 
the training period regardless of condition, establishing the predicted general learning effect. 
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Figure 11. Reaction times towards invalid trials 
 
Note. The mean average of reaction times towards invalid trials (i.e. negative valence faces) from 
each of the 14-days intervention for both of the groups.   
 
3.4.2 Fluctuations in biases 
The other secondary aim was to investigate possible fluctuations, entailing a difference in 
reaction times between valid and invalid trials in the two groups. There was however no main 
effect of time, meaning no statistically significant difference in reaction times between valid 
and invalid trials regardless of condition, Wilks`Lambda = .72, F (13, 36) = 1.10, p = .42. 
There was also no statistically significant interaction effect between the ABM conditions and 
differences in reaction times between valid and invalid trials, Wilks` Lambda = .68, F (13, 
36) = 1.33, p = .32. See Figure 12. 
In sum there appeared to be fluctuations in both groups in differences in reactions times 
between valid and invalid trials, as depicted in Figure 12, but no statistically significant 
effects.  
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Figure 12. Total difference in reaction times between valid and invalid trials 
 
The mean average of the difference in reaction times between valid and invalid trials from each of the 
14-days intervention for both of the groups.  
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4 Discussion 
 
4.1 Main findings  
4.1.1 Basal circadian cortisol variations 
The first hypothesis of the current study was to investigate if basal circadian cortisol 
levels would decrease in the evening and increase from the first to the second morning 
sample, in both of the groups at all three times of measurement. In accordance with this 
hypothesis, there was a consistent finding of the predicted basal circadian cortisol variations 
both before and after the ABM intervention and at one-month follow up. This was an 
important finding in order to validate the expected curve, before possible effects of the ABM 
task on these basal circadian cortisol variations could be evaluated.  
 
4.1.2 The association between basal circadian cortisol variations and the ABM task  
The second hypothesis of the study was to investigate if there was a difference in basal 
circadian cortisol variations between the two groups after the 14-days intervention. The third 
hypothesis was that this effect would be more apparent at one-month follow up than after the 
14-days intervention. The findings were at odds with both of these hypotheses. There was no 
statistically significant difference between the two groups with regards to changes in basal 
circadian cortisol, at either of the two times of measurement after the intervention. This 
entailed both the basal circadian curves, and for the differences scores between the cortisol 
samples at the different times of measurement.  
The estimated power of the results was small. Meaning that if there was an actual 
decrease of cortisol in the predicted direction, there would be a small probability of finding 
that effect in the current sample given its total number of participants. Looking at tendencies 
in the predicted direction in the data was therefore of interest.  
 
4.1.3 Difference scores in basal circadian cortisol between the different times of 
measurement 
The predicted direction of cortisol levels was a decrease in concentrations for all three 
samples. When calculating difference scores between the different times of measurement, 
positive scores would indicate an increase in cortisol concentrations and negative scores 
would indicate a decrease in cortisol concentrations. If there was any tendencies in the 
predicted direction with regards to differences scores, the expect results would be a decrease 
in cortisol in the difference scores for both the Evening, Morning 1, and Morning 2 samples, 
	  33	  
between 14-days follow up and pre intervention, and an even greater decrease in the 
difference scores between one-month follow up and pre intervention, and a moderate 
decrease between one-month and 14-days follow up. See Table 3.  
In sum, there appeared to be a tendency of a decrease in cortisol concentrations in the 
active ABM group for the Morning 2 samples from pre to 14-days follow up, from 14-days 
follow up to one-month follow up, and from pre to one-month follow up. This was a non-
statistically significant decrease in cortisol concentrations in the predicted direction. As 
predicted, the greatest difference was between pre and one-month follow up samples, and a 
slightly smaller decrease between 14-days follow up and one-month. There was also some 
decrease between the different times of measurement in the placebo ABM group, but these 
were slightly smaller that in the active group, and less consistent.  
It appeared however that the decrease in cortisol in the predicted direction only was a 
consistent tendency for the Morning 2 samples in the active ABM group. The cortisol 
awakening response has been the most prominent marker of a heightened basal cortisol level 
in previously depressed individuals. Studies have found a blunted basal circadian cortisol 
curve, which also entails evening samples. Investigating these basal variations over a 24 
hours period can be an important contribution in order to increase knowledge of possible 
fluctuations in basal cortisol in relation to depression. However, differences in cortisol 
concentrations in the evening might need to be established through several cortisol samples 
taken over one or several consecutive hours, in order to reveal possible elevations and 
reductions in cortisol levels.  
The standard errors of the above-discussed findings were high. There can be great inter-
individual variance in cortisol levels, which may partly explain this. In addition, the 
difference between two cortisol samples can entail a high degree of variation, both between 
subjects and between different times of measurements for an individual. Thus interpretation 
of the tendencies must be done with caution due to the high standard errors. However, one 
can speculate that these tendencies might have been statistically significant in a bigger 
sample.  
 
4.1.4 The ABM learning effect 
As one of the secondary aims, the study investigated if both of the groups would show a 
learning effect from the ABM task during the 14-days intervention, defined as a statistically 
significant decrease in reaction time. There was a general learning effect of the ABM task in 
both of the groups, expressed as a statistically significant decrease in reaction times towards 
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both valid and invalid trials in both of the groups. Establishing this general learning effect 
validates the fact that the participants completed their sessions during the 14-days 
intervention in a satisfactory way. This should be established before one can evaluate 
possible effects of the ABM task.  
There was a statistically significant decrease in reaction times in both of the groups 
between the first days of the ABM task. This learning effect gradually flattened around day 
4-6, and then there were some fluctuations in reaction times over the remaining days. It 
appeared that the attention bias training did not have a specific effect on positive vigilance.  
 
4.2 Additional findings and considerations  
4.2.1 The ABM task – fluctuations in attention biases  
Since the current study was able to establish a general learning effect of the ABM task 
in both of the groups, the non-statistically significant findings in the current study was not 
due to lack of having completed the intervention.   
Another secondary aim was to investigate possible fluctuations in biases. There were 
no statistically significant effects, but there were however some tendencies in the direction of 
more noticeable fluctuations in the placebo ABM group compared to the active ABM group.  
Figure 12. shows differences in reaction times between valid and invalid trails in the 
two groups. This curve shows that at the first day, the placebo group in general shows a faster 
reaction time towards negative stimuli than towards positive stimuli. While the active ABM 
group in general shows a faster reaction time towards positive stimuli. When looking at the 
differences in reaction times between the two groups on the first day, it gives the impression 
of a pre-existing positive bias in the active ABM group and a negative bias in the placebo 
group. However, when looking at these biases from day to day, they appear to be 
continuously shifting between negative and positive. Measuring a pre-existing bias can 
therefore be difficult. Using baseline measures where reaction times towards positive and 
negative valence faces before and after an intervention through a dot-probe paradigm is 
compared, can be a poor measure of the effects of the ABM intervention.  
Such baseline measures before and after CBM interventions have been frequently used. 
Apparent statistically significant effects might then be due to other unexplained factors (i.e. 
error variance) when measuring biases as stable traits before and after the interventions.  
If attention biases are viewed as more dynamic processes (Zvielli et al., 2015) these 
biases would be expected to fluctuate, but the degree of fluctuations, might be affected by the 
ABM task. As depicted in Figure 12., the fluctuations within the active ABM group appear to 
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be smaller than in the placebo ABM group. This might indicate that the ABM task can affect 
the degree of fluctuations, which could have explained the tendency of a reduction in basal 
cortisol in the predicted direction in the active group. The ABM task aims to modify a 
negative attention bias. This bias might however be a more dynamic process that fluctuates in 
accordance with mood, and a reduction in fluctuations might indicate a less easily evoked 
negative attention bias, that is less influenced by negative mood.  
Establishing pre-existing biases can be challenging, due to great fluctuations as shown 
in Figure 12., and also pointed out in the study by Zvielli et al. (2015). Trying to establish the 
dynamics of attention biases preceding ABM interventions, could give a better indication of 
possible effects. The current study showed some of these fluctuations, and a possible 
stabilization of these, but did not investigate what affected them. This could be connected to a 
number of factors like current symptom level, number of previous depressive episodes, genes 
and comorbid psychiatric diagnoses. The current study included factors with regards to 
symptom level, age, education and gender. However, these were measured in order to look 
for possible group differences, and not to look at possible mediating effects they could have 
on the association between the ABM task and basal cortisol. 
In their review on the current standing on cognitive bias modification research and 
recommendations for future research, Koster and Bernstein (2015) emphasize that studies 
with null findings make important contributions when it comes to the future development and 
adjustments to cognitive bias modifications methods. The findings from the currents study 
are therefore interesting to further our understanding of possible adjustments needed to the 
ABM task. Especially with regards to pre-existing and fluctuating biases, which might 
contribute the field to “take a step back to move forward”(Koster & Bernstein, 2015).  
 
4.2.2 Factors influencing degree of malleability in depressive schemas 
An attention bias can as mentioned be viewed as being at the centre of depressive 
schemas. These schemas become more easily activated with each depressive episode, and 
more resistant to change during an episode. In the current study, there were differences 
between the two groups that could have had an impact on degree of malleability in the 
depressive schemas, and therefore modification of an attention bias. In addition, the sample 
in the current study might have been a more heterogeneous sample of previously depressed 
compared to previous studies within the field.  
There was a higher mean average of previous depressive episodes in the active ABM 
group compared to the placebo ABM group. Given the fact that 30% relapses within 3 
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months of their depressive episode (Browning et al., 2012), one can assume that a portion of 
the participants would enter a new depressive episodes within the one-month period. As 
mentioned, the risk for relapse increases with the number of previous episodes, like a 
kindling effect. This would be especially relevant for the active ABM group, given their 
higher mean average of previous episodes. Another fact that supports this assumption is that 
the mean average of BDI-II scores in the active ABM group was just within the cut-off 
criteria for remission. This cut-off criteria for remission might have been too liberal. Leading 
to a high sensitivity entailing correctly identifying those who were in remission, but maybe a 
reduced specificity in correctly identifying those who were not in current remission, but 
rather entering a new depressive episode.  
In sum, there were a higher number of previous depressive episodes and BDI-II scores in 
the active ABM group. An attention bias would then be difficult to alter, when taken into 
consideration the assumption that the more activated the depressive schemas are, the more 
resistant to change they become. Also, number of previous depressive episodes, have been 
indicated to influence the degree of cognitive flexibility also in remission phases (Biringer et 
al., 2005). In people with a reduced degree of cognitive flexibility, it might be more difficult 
to affect their cognitive biases through associative learning.  
The sample in the current study might better have reflected the heterogeneous group 
of previously depressed, compared to previous, similar studies that have had stricter 
remission criteria’s. Some studies have had a time criteria for remission of six months 
(Browning et al., 2012), while the current study had a time criteria for remission of only two 
weeks. Studies have shown that individuals with a reduced responsiveness of the HPA axis in 
remission, are at higher risk for relapse (Zobel et al., 2001). Having been in remission for an 
extended amount of time might therefore indicate a better functioning HPA axis, more 
susceptible to experimental changes. Depressive schemas would then be less resistant to 
change, which would entail both the attention bias component and cortisol component of the 
schemas. Given the inter-related areas involved in both a negative attention bias and stress 
responses like the amygdala, it is likely that these processes will both reinforce and maintain 
each other.  
The participants in the current study might have had more easily activated depressive 
schemas and subsequent rigidity in attention biases and HPA functioning that could have 
affected the null-findings. This is an important consideration when taking a step back to 
evaluate how ABM paradigms best can target vulnerabilities for maintenance and 
reoccurrence in the heterogeneous population of previously depressed.  
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However, the possible more heterogeneous sample in the current study, and the 
differences between the two groups, might have posed a challenge in obtaining statistically 
significant results in the predicted direction.   
 
4.2.3 Comorbidity in depression and anxiety disorders  
In the current study, many of the participants had a comorbid anxiety disorder, which 
could have influenced the lack of the predicted outcome effects from the ABM task on basal 
circadian cortisol. 
The content specific hypotheses predicts that people suffering from depression or 
anxiety disorders, will show a content specific attention bias. These different, content specific 
attention biases in depression and anxiety, might occur at different stages of attention 
processes (Browning et al., 2010; Gotlib et al., 2004). The current study used an ABM task 
were faces were presented for either 1000ms or 500ms. Given the high comorbidity in the 
sample, the phenomenon of a content specific bias in depression, might not have been present 
in all of the participants in the sample. In addition, using both presentation times of 500ms 
and 1000ms, might not have targeted specifically enough the later stages of attention 
processes where the bias in depression might be most evident.  
The sample in the current study might have given a more correctly reflection of the 
heterogeneous population of individuals in remission from depression, with regards to 
comorbidity. However, this complexity in the sample might have affected the results.  
 
4.3 Sample size and estimated power 
The different factors discussed so far, are important considerations in understanding the 
null-findings. However, the factors used in the analyses, both the ABM task and basal 
cortisol also depend on power. Estimated power of the findings revealed that if there had 
been a statistically significant difference in the population, there would be a low probability 
of finding the difference in the current sample, given its size. A high number of participants 
in a sample can make it sensitive to small, but sometimes insignificant effects. This can 
increase the probability for statistically significant findings that can also result in an 
overestimation of the effects of an intervention, a type 1 error. Whereas a small sample size 
can be more vulnerable of not detecting small effects that might be of significance, which 
decrease the probability of statistically significant findings, resulting in a possible under 
estimation of effects, a type 2 error (Field, 2013).  
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Even though the discussed reasons for possible null findings are important considerations, 
it is also important to view them in light of the low estimated power, which can be influence 
by a number of factors, but that also in itself could have led to an under estimation of possible 
effects of the ABM task on basal circadian cortisol variations.  
 
4.4 Strength and limitations 
4.4.1 Participants  
The participants in the current study were recruited from an outpatient clinic. The sample 
might therefore be said to be representative of the population of previously depressed. This 
gives a good ecological validity, meaning that the sample reflects the actual target group with 
respects to variations in age, gender, and educational level, in addition to clinical status. 
Indicating a translation of possible effects to real-world settings (Field, 2013). The 
heterogeneity in the sample did also pose some challenges, due to the within-subjects 
variations with regards to several factors. However, studying a heterogeneous sample like 
this when assessing the association between the ABM task and residual symptoms (e.g. basal 
cortisol) is viewed as a strength in terms of possible translation to clinical applications of the 
task.  
 
4.4.2 Number of training sessions in the current ABM task 
The ABM task used in the current study had a relatively high number of sessions, 28, 
during the 14-days intervention, compared to other studies using similar procedures. 
Extending number of session but also the time range for the administration of sessions, gives 
an increased probability of cognitive changes that can be longer lasting (MacLeod et al., 
2009). The time frame for the administration of the ABM task and number of sessions was 
therefore considered a strength in the current study.  
 
4.4.3 Assessment of current symptom level and residual symptoms 
Establishing reliable and valid assessments of current level of depressive symptoms is 
important when investigating the possible effects of an intervention like the ABM task on 
residual symptoms. When investigating the effect of the ABM task on residual symptoms, a 
combination of well validated self-report measures and physiological measures have been 
recommended in the literature(MacLeod et al., 2009). The current study used cortisol as an 
outcome measure, which would reflect possible physiological changes in depressive schemas 
as an effect of an attention modification, and the BDI-II as a self-report measure of current 
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level of depressive symptoms. Using a combination of a well-established valid self-report 
measure like the BDI-II and a physiological measurement like cortisol, are considered as 
strengths in the current study with regards to measurement.  
 
4.4.4 Factors influencing basal circadian cortisol concentrations 
The current study used three cortisol samples to establish basal circadian cortisol 
variations, as previously mentioned. Saliva cortisol samples can be unreliable when looking 
at samples separately, without creating a baseline consisting of several samples taking during 
one consecutive hour or hours. Factor influencing the samples leading to a possibly higher 
error variance can be circadian rhythms, gender, age (Kirschbaum & Hellhammer, 1994) or 
stressful events of the current morning or evening of the sampling time and antidepressants. 
 In some studies investigating the reliability of saliva cortisol samples, it has been noted 
that taking morning cortisol samples during the 30-60 first minutes after awakening with 15 
minutes intervals, reduced the effects of factors which normally can have an effect on 
baseline levels (Pruessner et al., 1997). Using only one sample from the evenings, and two in 
the mornings with a 15-minute interval, might not have been sufficient to establish a stable 
measurement of basal circadian variations. The following factors were considered especially 
influential on basal cortisol in the current study; seasonal changes in cortisol, cortisol 
sampling time, age and antidepressants.  
Seasonal changes consisting of longer or shorter periods with natural light during the 
daytime affect cortisol levels (Wehr, 1998). Even though artificial light in our modern society 
has made these seasonal changes less, it can still affect cortisol variations. The current study 
used cortisol data collected over one consecutive year, which means that the comparison of 
cortisol samples between the two groups, consisted of cortisol from all through the different 
season of the year with possibly subsequent variations.  
Cortisol levels are also affected by circadian rhythms (Van Cauter et al., 1996). 
Variations in sleeping patterns, bedtime hours and time of wakening will therefor affect basal 
cortisol levels. The participants in the current study were instructed to take the saliva samples 
within a given time frame. However, many of the participants were not able to abide by these 
sampling times due to different circumstances ranging from simply forgetting to do the 
sample, to variations in circadian rhythms resulting in getting up after 09 for example. The 
cortisol data was not divided into time of sampling. The participants could have been divided 
into different groups according to sample time and circadian rhythms when analyzing basal 
circadian cortisol variations.   
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Since there was no statistically significant difference between the two groups with 
regards to age, it was not assessed as being a necessary covariate in the analyses. However, 
when using only three cortisol samples, the influence of factors like age, can lead to a less 
robust and reliable measure of basal cortisol, as previously mentioned. Age has been shown 
to impact variations in cortisol greatly (Van Cauter et al., 1996). The current sample 
consisted of participants with a range in age between 27-67. Not controlling for possible 
differences in cortisol variations due to age when only using three samples, could have been a 
limitation in establishing a reliable measure of basal cortisol, and revealing possible effects 
between the ABM task and basal cortisol.  
The current study did not control for whether or not the participants were medicated 
with antidepressants. Different forms of antidepressants affect the HPA axis function, by 
increasing the number of GR receptors (Pariante et al., 2004), which often has been down 
regulated, or destroyed due to excessive cortisol release. When antidepressants are effective 
and work in the intended way, there can be an increase in both GR and MR that leads to a 
more functional negative feedback system in the HPA axis. Resulting in a better functioning 
stress response system, able to regulate itself when faced with stressors. If several of the 
participants were medicated with antidepressants during the intervention and at one-month 
follow up, this could have affected cortisol levels in the direction of more normal levels that 
would not be affected by possible effects by the ABM task.  
There were also some constraints in the biological analysis of some of the cortisol 
samples, especially for the one-month follow up samples, which was the main reason there 
were only full cortisol sample sets for 42 of the 52 participants at one-month follow up.   
In sum, both seasonal changes, variations in time of sampling, age, and the possible use 
of antidepressants, could have contributed to an unreliable measure of basal circadian 
cortisol. Not adjusting for these factors as covariates could therefore have been a limitation 
that might have contributed to masking possible effects of the ABM task.  
 
4.5 A note on covariates  
Since the use of antidepressant and age has both been shown to strongly influence cortisol 
concentrations, not adjusting for them as covariates could have been a clear limitation. The 
aim of including covariates is to reduce error variance (i.e. variance not explained by the 
independent variable). Some of the unexplained variance can then be explained by the 
covariates that can affect the dependent variable, which can lead to an increase in power 
estimations (Field, 2013). However, using several covariates can also lead to a reduction in 
	  41	  
power, and must therefor be used with caution. In addition, within the scope of the current 
study it was not possible to investigate all of the possible confounding variables with regards 
to the association between the ABM task and cortisol. Finding alternative ways to deal with 
confounding variables might entail dividing the sample in different group when assessing the 
impact on these different factors on the associated relationship between attention 
modification and cortisol.   
 
4.6 Suggestions for future research 
Regardless of the possible mentioned limitations, the null-findings in the current 
study is considered to be a small but important contribution in the field of ABM targeted 
interventions for vulnerability of reoccurrence in depression. In the future, ABM procedures 
could represent a viable alternative to secondary prevention of reoccurrence in depression. In 
order to evaluate whether or not this method could be effective and translated into a clinical 
setting, studies aiming to better understand and optimizing the method are important.  
One recommendation would be to investigate the possible effects of third variables. 
This could be important in order to get a better understanding of factors that could mediate 
the effect of the ABM on residual symptoms in depression. Third variables that would be 
interesting to investigate more closely are number of previously depressive episodes and 
comorbid anxiety disorder. Given the high comorbidity between anxiety disorders and 
depression, these affective disorders share some features, but are more distinct with regards 
to others, which include differences in attention biases. Investigating samples of previously 
depressed with no comorbid anxiety disorders and using stimuli durations for 1000ms, could 
be one option. Another option is to investigate possible combinations of duration of stimuli 
presentation and stimuli content. In order to assess what form of the ABM task that would be 
most efficiently in such a heterogeneous population.  
Number of previous depressive episodes could as mentioned have an effect on degree 
of malleability in depressive schemas, which should be investigated more closely.  
Looking at pre-existing attention biases as dynamic processes could yield interesting 
results, in the further development of the ABM task.  
Establishing a robust measure of basal cortisol with an increased number of cortisol 
samples that could reduce degree of possible error variance could be an important step.  
Looking at circadian variations through basal circadian cortisol variations however, and not 
only the cortisol awakening response, is recommended in order to increase the understanding 
of basal cortisol as a residual symptoms in depression. The CAR has been widely 
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investigated, and has been established as being increased both during depressive episodes and 
remission periods. In order to get a more comprehensive understanding of basal cortisol in 
relation to attention in depression, circadian variations will possibly to a greater degree 
reflect the overall functioning of the HPA axis.  
 
4.7 Clinical implications  
Finding novel ways to prevent reoccurrence in depression is an important step in 
reducing the burden of the disorder. As shown in the study by Schmidt et al. (2009), ABM 
procedures can markedly reduce symptoms in affective disorders, especially anxiety 
disorders. This indicates a possible translational value of the ABM procedure to clinical 
settings, and it might be possible in the future to produce similar effects in samples of 
previously depressed individuals in remission.  
 The finding in the current study has made some contributions with regards to 
possible needed adjustments and considerations when using the ABM task.  
The ABM procedure can in the future prove to be an effective alternative in the 
prevention of reoccurring depressive episodes; it can be used by people in their own homes 
administrated in a computerized form, which can be maintained over time. This might prove 
to be a cost-effective intervention in treating reoccurrence in depression.  
 
4.8 Conclusion 
The aim of the current study was to investigate the association between attention bias 
modification and basal circadian cortisol in individuals vulnerable for reoccurrence in 
depression. Both of the groups showed the expected basal circadian variations, with a 
decrease in cortisol concentrations in the evening, and an increase from the first to the second 
morning sample. The association between the ABM task and basal circadian cortisol was 
however not statistically significant. There were however tendencies in the predicted 
direction of a reduction in basal cortisol in the active ABM group, mainly for the morning 
cortisol samples.  
Both of the groups showed a learning effect towards both valid and invalid trials. 
There also appeared to be a fluctuation in attention biases when comparing the differences in 
reaction times between valid and invalid trials. These fluctuations were greater in the placebo 
ABM group compared to the active ABM group. The reduction in fluctuation in biases, might 
explain the tendencies of a reduction in basal cortisol on the active ABM group.  
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A number of factors could have influenced the current null-findings: current symptom 
level, number of previous depressive episodes, criteria for length of time in remission, 
comorbid anxiety disorders and establishing reliable basal circadian cortisol measures. In 
addition, the estimated power in the current sample was low, which could have made under 
estimations of possible effects likely.  
The null-findings in the current study is considered to be a small but important 
contribution to the field of attention bias modification and depression, in terms of re-
evaluating different aspects of the intervention with regards to fluctuations in biases, duration 
and content of stimuli, possible confounding third variables, and establishing reliable 
outcome measures.  
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